Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler

  • Authors:
    • Hidefumi Sasaki
    • Katsuhiro Okuda
    • Osamu Kawano
    • Katsuhiko Endo
    • Haruhiro Yukiue
    • Tomoki Yokoyama
    • Motoki Yano
    • Yoshitaka Fujii
  • View Affiliations

  • Published online on: Saturday, September 1, 2007
  • Pages: 623-628
  • DOI: 10.3892/or.18.3.623

Abstract

Activating mutations of Ras gene families have been found in a variety of human malignancies, including lung cancer, suggesting their dominant role in tumorigenesis. Many studies have showed that the Kras gene is activated by point mutations in ≈15-20% of non-small cell lung cancers (NSCLCs), however, there are only a few reports on Nras mutations in NSCLC. We have genotyped Nras mutation status (n=195) and Kras mutation status (n=190) in surgically treated lung adenocarcinoma cases. The presence or absence of Nras and Kras mutations was analyzed by real-time quantitative polymerase chain reaction (PCR) with mutation-specific sensor and anchor probes. EGFR mutation status at kinase domain has already been reported. Nras mutation was found in 1 of 195 patients. This mutation was a G-to-T transversion, involving the substitution of the normal glycine (GGT) with cystein (TGT) and thought to be a somatic mutation. The patient was male and a smoker. Kras mutant patients (11.1%; 21/190) had a significantly worse prognosis than wild-type patients (p=0.0013). Eighty-two EGFR mutations at kinase domain had exclusively Nras or Kras mutations. Although Nras gene mutation might be one of the mechanisms of oncogenesis of lung adenocarcinoma, this was a very rare event. Further studies are needed to confirm the mechanisms of Nras mutations for the sensitivity of molecular target therapy for lung cancer.
Journal Cover

September 2007
Volume 18 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

2013 Impact Factor: 2.191
Ranked #33/202 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Sasaki, H., Okuda, K., Kawano, O., Endo, K., Yukiue, H., Yokoyama, T., Yano, M., & Fujii, Y. (2007). Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncology Reports, 18(3), 623-628.
MLA
Sasaki, Okuda, Kawano, Endo, Yukiue, Yokoyama, Yano, and Yoshitaka Fujii. "Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler." Oncology Reports Oncology Reports 18.3 (2007): 623-628.
Chicago
Sasaki, Okuda, Kawano, Endo, Yukiue, Yokoyama, Yano, and Yoshitaka Fujii. "Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler." Oncology Reports Oncology Reports 18 no. 3 (2007): 623-628.